Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Cosmederm Gains CFDA Approval for Topical Skin Treatment

publication date: Aug 12, 2013
Cosmederm Bioscience of San Diego, Hong Kong and Shenzhen, received CFDA approval for TriCalm® Anti-Itch Hydrogel, an OTC topical treatment for itching, burning or stinging skin conditions. Cosmederm’s TriCalm products are steroid-free skincare products that have been tested to provide relief from itching and burning without causing side effects. In April 2013, the company’s Tricalm Eczema Creme was approved for marketing by the CFDA, its first China approval. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital